- Home
- SLRX vs SXTP Comparison
SLRX vs SXTP Comparison
Compare SLRX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- SXTP
- Stock Information
- Founded
- SLRX N/A
- SXTP 2010
- Country
- SLRX United States
- SXTP United States
- Employees
- SLRX N/A
- SXTP N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SLRX Health Care
- SXTP Health Care
- Exchange
- SLRX Nasdaq
- SXTP Nasdaq
- Market Cap
- SLRX 2.1M
- SXTP 2.4M
- IPO Year
- SLRX N/A
- SXTP 2023
- Fundamental
- Price
- SLRX $1.34
- SXTP $0.45
- Analyst Decision
- SLRX
- SXTP Hold
- Analyst Count
- SLRX 0
- SXTP 1
- Target Price
- SLRX N/A
- SXTP N/A
- AVG Volume (30 Days)
- SLRX 71.1K
- SXTP 5.8M
- Earning Date
- SLRX 03-21-2025
- SXTP 03-31-2025
- Dividend Yield
- SLRX N/A
- SXTP N/A
- EPS Growth
- SLRX N/A
- SXTP N/A
- EPS
- SLRX N/A
- SXTP N/A
- Revenue
- SLRX N/A
- SXTP $462,612.00
- Revenue This Year
- SLRX N/A
- SXTP $141.35
- Revenue Next Year
- SLRX N/A
- SXTP $175.16
- P/E Ratio
- SLRX N/A
- SXTP N/A
- Revenue Growth
- SLRX N/A
- SXTP 128.99
- 52 Week Low
- SLRX $1.22
- SXTP $0.41
- 52 Week High
- SLRX $7.20
- SXTP $7.20
- Technical
- Relative Strength Index (RSI)
- SLRX 32.32
- SXTP 33.01
- Support Level
- SLRX $2.08
- SXTP $0.47
- Resistance Level
- SLRX $1.94
- SXTP $0.67
- Average True Range (ATR)
- SLRX 0.14
- SXTP 0.10
- MACD
- SLRX -0.09
- SXTP 0.00
- Stochastic Oscillator
- SLRX 2.80
- SXTP 12.96
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.